| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 65971 |
PC:Cardiolipin Liposomes,磷脂酰胆碱-心磷脂脂质体 |
136 |
axc |
2024-12-23 |
| 65972 |
HOOC(CH2)COOH，羧基-烷烃-羧基 |
190 |
h |
2024-12-23 |
| 65973 |
3032600-19-1，CSD-CH2(1,8)-NH2 |
66 |
wyh |
2024-12-23 |
| 65974 |
HS-(CH2)2-OH，巯基-烷烃-羟基 |
115 |
h |
2024-12-23 |
| 65975 |
TMCL Liposomes,特性与功能 |
84 |
axc |
2024-12-23 |
| 65976 |
MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH |
82 |
wyh |
2024-12-23 |
| 65977 |
3-巯基丙酸修饰的聚1-半胱氨酸[P(Cys-SS-CH2CH2COOH)] |
119 |
h |
2024-12-23 |
| 65978 |
TOCL Liposomes,心磷脂脂质体,定制服务 |
232 |
axc |
2024-12-23 |
| 65979 |
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ-O-CH2-CH2-CH2-NH2，抗原四糖-βO-氨丙基 |
116 |
wyh |
2024-12-23 |
| 65980 |
Cardiolipin Liposomes,心磷脂脂质体 |
151 |
axc |
2024-12-23 |
| 65981 |
Biotin-PEG(4)-MeTz，1962919-31-8，生物素-聚乙二醇(4)-MeTz |
116 |
wyh |
2024-12-23 |
| 65982 |
DOTAP:DOPC Liposomes,特性与应用 |
94 |
axc |
2024-12-23 |
| 65983 |
HOOC-PMeOx(50)-N3，26375-28-0，HOCOCH2(C4H7NO)50N3 |
73 |
wyh |
2024-12-23 |
| 65984 |
Fmoc-Tyr(CH2-Chx)-OH，N-α-(9-芴基甲氧基羰基)-4-环己基甲氧基-L-苯丙氨酸 |
165 |
wyh |
2024-12-23 |
| 65985 |
cas:1337889-01-6，Ald-Ph-amido-PEG11-C2-NH2 |
73 |
zyl |
2024-12-23 |
| 65986 |
长链脂肪酸衍生物MAMA-(CH2)17COOH |
102 |
h |
2024-12-23 |
| 65987 |
cas:1807501-86-5，2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oate |
75 |
zyl |
2024-12-23 |
| 65988 |
1059189-65-9，m-PEG4-CH2-aldehyde |
72 |
wyh |
2024-12-23 |
| 65989 |
cas:886209-60-5，perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate |
85 |
zyl |
2024-12-23 |
| 65990 |
DOOCCH2CH2COOD烷基链试剂 |
92 |
h |
2024-12-23 |
| 65991 |
cas:1092654-47-1，Azido-PEG3-CH2CO2-NHS |
74 |
wyh |
2024-12-23 |
| 65992 |
N-芴甲氧羰基-五聚乙二醇-乙酸，Fmoc-NH-PEG5-CH2COOH |
83 |
wyh |
2024-12-23 |
| 65993 |
cas:1232769-29-7，Mal-CO-PEG5-NHS ester |
113 |
zyl |
2024-12-23 |
| 65994 |
氨基-PEG4-丁酸，Amino-PEG4-(CH2)3CO2H |
89 |
wyh |
2024-12-23 |
| 65995 |
cas:1342211-31-7， MC-Val-Ala-OH |
74 |
zyl |
2024-12-23 |
| 65996 |
cas:150244‐18‐1，sulfo-LC-SPDP |
123 |
zyl |
2024-12-23 |
| 65997 |
Azido-PEG3-CH2CO2Me，叠氮-三聚乙二醇-CH2CO2甲基 |
126 |
wyh |
2024-12-23 |
| 65998 |
cas:663598-89-8，1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
103 |
zyl |
2024-12-23 |
| 65999 |
99mTc-HYNIC-PEG4-E[PEG4-c（RGDfk）]2(即99mTc-3PRGD2) |
124 |
wyh |
2024-12-23 |
| 66000 |
cas:121115-30-8 SPDP-sulfo 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid |
121 |
zyl |
2024-12-23 |
| 66001 |
MP-PEG8-Val-Ala-PAB-(imp)PBD的组成部分 |
107 |
wyh |
2024-12-23 |
| 66002 |
perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate |
129 |
zyl |
2024-12-23 |
| 66003 |
MC-Val-Cit-PABC-BF211，抗体药物偶联物(ADCs) |
116 |
wyh |
2024-12-23 |
| 66004 |
2,3,4,5,6-pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate |
72 |
zyl |
2024-12-23 |
| 66005 |
DOPG:DOPC Liposomes,磷脂酰甘油与磷脂酰胆碱脂质体 |
183 |
axc |
2024-12-23 |
| 66006 |
cas:1353012-00-6，perfluorophenyl 1-azido-3,6,9,12-tetraoxapentadecan-15-oate |
94 |
zyl |
2024-12-23 |
| 66007 |
1V209-PEG23-TA ， 4，7，10-三氧杂-1，13-十三烷二胺和α-甘露糖 |
132 |
wyh |
2024-12-23 |
| 66008 |
cas:943858-70-6，Azidobutyric acid NHS ester |
90 |
zyl |
2024-12-23 |
| 66009 |
DOPG Liposomes,磷脂酰甘油脂质体 |
94 |
axc |
2024-12-23 |
| 66010 |
(64)Cu-NOTA-PEG4-LLP2A的结构组成 |
68 |
wyh |
2024-12-23 |
| 66011 |
99mTc(CO)3-DPA-DBCO-PEG4-CTT-54的显像效果 |
134 |
wyh |
2024-12-23 |
| 66012 |
DOPS:DOPC Liposomes,磷脂酰丝氨酸与磷脂酰胆碱脂质体 |
226 |
axc |
2024-12-23 |
| 66013 |
2,5-dioxopyrrolidin-1-yl 11-oxo-4,7,13-trioxa-10-azahexadec-15-yn-1-oate |
97 |
zyl |
2024-12-23 |
| 66014 |
DOPC Liposomes,二油酰磷脂酰胆碱脂质体 |
153 |
axc |
2024-12-23 |
| 66015 |
DTPA(Gd)-PEG8-(FY)3的结构特点 |
89 |
wyh |
2024-12-23 |
齐岳微信公众号
官方微信
库存查询